The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Fascioliasis


High impact information on Fascioliasis


Chemical compound and disease context of Fascioliasis


Biological context of Fascioliasis


Anatomical context of Fascioliasis


Gene context of Fascioliasis


Analytical, diagnostic and therapeutic context of Fascioliasis


  1. Proline induced hemolytic anemia in fascioliasis. Coffin, J.D., McGarry, M.P., Isseroff, H. Proc. Soc. Exp. Biol. Med. (1984) [Pubmed]
  2. Effect of food on the bioavailability of triclabendazole in patients with fascioliasis. Lecaillon, J.B., Godbillon, J., Campestrini, J., Naquira, C., Miranda, L., Pacheco, R., Mull, R., Poltera, A.A. British journal of clinical pharmacology. (1998) [Pubmed]
  3. Hyperendemic fascioliasis associated with schistosomiasis in villages in the Nile Delta of Egypt. Esteban, J.G., Gonzalez, C., Curtale, F., Muñoz-Antoli, C., Valero, M.A., Bargues, M.D., el-Sayed, M., el-Wakeel, A.A., Abdel-Wahab, Y., Montresor, A., Engels, D., Savioli, L., Mas-Coma, S. Am. J. Trop. Med. Hyg. (2003) [Pubmed]
  4. Immunoaffinity fractionation of Schistosoma mansoni worm antigens using human antibodies and its application for serodiagnosis. Boctor, F.N., Shaheen, H.I. Immunology (1986) [Pubmed]
  5. Isolation and purification of a diagnostic antigen for bovine cysticercosis by hydrophobic chromatography. Hayunga, E.G., Sumner, M.P. Vet. Immunol. Immunopathol. (1991) [Pubmed]
  6. Single treatment of invasive fascioliasis with triclabendazole. Loutan, L., Bouvier, M., Rojanawisut, B., Stalder, H., Rouan, M.C., Buescher, G., Poltera, A.A. Lancet (1989) [Pubmed]
  7. Treatment of human fascioliasis with niclofolan. Eckhardt, T., Heckers, H. Gastroenterology (1981) [Pubmed]
  8. Successful treatment of acute fascioliasis with bithionol. Bacq, Y., Besnier, J.M., Duong, T.H., Pavie, G., Metman, E.H., Choutet, P. Hepatology (1991) [Pubmed]
  9. Molecular cloning and expression of Cu/Zn-containing superoxide dismutase from Fasciola hepatica. Kim, T.S., Jung, Y., Na, B.K., Kim, K.S., Chung, P.R. Infect. Immun. (2000) [Pubmed]
  10. Vaccination with cathepsin L proteinases and with leucine aminopeptidase induces high levels of protection against fascioliasis in sheep. Piacenza, L., Acosta, D., Basmadjian, I., Dalton, J.P., Carmona, C. Infect. Immun. (1999) [Pubmed]
  11. Fascioliasis: nitrogen balance studies and the disposition of excessive proline in rats. Chi, C.W., Isseroff, H. J. Nutr. (1979) [Pubmed]
  12. Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru. Favennec, L., Jave Ortiz, J., Gargala, G., Lopez Chegne, N., Ayoub, A., Rossignol, J.F. Aliment. Pharmacol. Ther. (2003) [Pubmed]
  13. Differential inhibition of rat hepatic glutathione S-transferase isoenzymes in the course of fascioliasis. Galtier, P., Vandenberghe, Y., Coecke, S., Eeckhoutte, C., Larrieu, G., Vercruysse, A. Mol. Biochem. Parasitol. (1991) [Pubmed]
  14. Fasciola hepatica cysteine proteinases: immunodominant antigens in human fascioliasis. Cordova, M., Herrera, P., Nopo, L., Bellatin, J., Naquira, C., Guerra, H., Espinoza, J.R. Am. J. Trop. Med. Hyg. (1997) [Pubmed]
  15. Control of human fascioliasis by selective chemotherapy: design, cost and effect of the first public health, school-based intervention implemented in endemic areas of the Nile Delta, Egypt. Curtale, F., Hassanein, Y.A., Savioli, L. Trans. R. Soc. Trop. Med. Hyg. (2005) [Pubmed]
  16. Pharmacokinetics and efficacy of triclabendazole in goats with induced fascioliasis. Kinabo, L.D., Bogan, J.A. J. Vet. Pharmacol. Ther. (1988) [Pubmed]
  17. Endoscopic therapy of fascioliasis resistant to oral therapy. Dowidar, N., El Sayad, M., Osman, M., Salem, A. Gastrointest. Endosc. (1999) [Pubmed]
  18. Fasciola hepatica: collagen deposition and other histopathology in the rat host's bile duct caused by the parasite and by proline infusion. Modavi, S., Isseroff, H. Exp. Parasitol. (1984) [Pubmed]
  19. Biochemical indicators of liver injury in calves with experimental fascioliasis. Anderson, P.H., Berrett, S., Brush, P.J., Hebert, C.N., Parfitt, J.W., Patterson, D.S. Vet. Rec. (1977) [Pubmed]
  20. Human fascioliasis: T cell subsets in liver before and after bithionol treatment. Abdel Rahman, Z.A., Fadali, G.A., Abou Basha, L.M. Journal of the Egyptian Society of Parasitology. (1990) [Pubmed]
  21. Electron microscopic study of the peritoneal macrophages of rats with chronic fascioliasis and the carcinogenic effect of diethylnitrosamine. Mizinska-Boevska, Y., Tsocheva, N., Polyakova-Krusteva, O., Krustev, L. Acta Vet. Hung. (1990) [Pubmed]
  22. IL-10, IFN-gamma and TNF-alpha in acute and chronic human fascioliasis. Osman, M.M., Abo-El-Nazar, S.Y. Journal of the Egyptian Society of Parasitology. (1999) [Pubmed]
  23. Biliary aspiration after administration of intravenous cholecystokinin for the diagnosis of hepatobiliary fascioliasis. Gómez Cerezo, J., Ríos Blanco, J.J., de Guevara, C.L., Barbado Hernández, F.J., Vázquez Rodríguez, J.J. Clin. Infect. Dis. (1998) [Pubmed]
  24. Identification of a 17-kilodalton Fasciola hepatica immunodiagnostic antigen by the enzyme-linked immunoelectrotransfer blot technique. Hillyer, G.V., Soler de Galanes, M. J. Clin. Microbiol. (1988) [Pubmed]
  25. Immunodiagnosis of Fasciola hepatica infection (fascioliasis) in a human population in the Bolivian Altiplano using purified cathepsin L cysteine proteinase. O'Neill, S.M., Parkinson, M., Strauss, W., Angles, R., Dalton, J.P. Am. J. Trop. Med. Hyg. (1998) [Pubmed]
  26. Circulating immune complexes in human fascioliasis. Relationship with Fasciola hepatica egg output. Sampaio-Silva, M.L., Santoro, F., Capron, A. Acta Trop. (1981) [Pubmed]
  27. Parasite-specific antibody profile in human fascioliasis: application for immunodiagnosis of infection. Maher, K., El Ridi, R., Elhoda, A.N., El-Ghannam, M., Shaheen, H., Shaker, Z., Hassanein, H.I. Am. J. Trop. Med. Hyg. (1999) [Pubmed]
  28. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole. Richter, J., Freise, S., Mull, R., Millán, J.C. Trop. Med. Int. Health (1999) [Pubmed]
  29. Characterisation of Fasciola gigantica adult 27-kDa excretory-secretory antigen in human fascioliasis. Tantrawatpan, C., Maleewong, W., Wongkham, C., Wongkham, S., Intapan, P.M., Nakashima, K. Parasitol. Res. (2003) [Pubmed]
  30. Detection of circulating E/S antigens in the sera of patients with fascioliasis by IELISA: a tool of serodiagnosis and assessment of cure. Shehab, A.Y., Hassan, E.M., Basha, L.M., Omar, E.A., Helmy, M.H., El-Morshedy, H.N., Farag, H.F. Trop. Med. Int. Health (1999) [Pubmed]
  31. Chemoprophylaxis of fascioliasis with triclabendazole. Boray, J.C., Jackson, R., Strong, M.B. New Zealand veterinary journal. (1985) [Pubmed]
WikiGenes - Universities